retatrutide clinical study ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial A Study of Retatrutide (LY3437943)
Pay in 4 interest-free payments of $5.56 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19


























